Positive results from the MATTERHORN Phase III trial showed perioperative treatment with AstraZeneca’s IMFINZI® (durvalumab) in combination with standard-of-care FLOT (fluorouracil, leucovorin, ...

Two cancer experts go head to head, arguing the case for and against a targeted prostate cancer screening programme.

Curious if the Cricut Joy Xtra can scan and cut like the bigger models? We tested it and uncovered what it can—and can’t—do, ...

Researchers led by a team from the University of Bath in the UK have achieved just that in a basic worm model of Parkinson's.

President Donald Trump is correct that prescription drugs cost too much. Families are struggling, and no one should have to ...

Former British Prime Minister Boris Johnson admits being a fan of artificial intelligence and has used the cutting-edge tech ...

Young people are suffering from 'brain rot', claims the AFR, and it's all due to social media. But there's another reason why ...

A new study says the right playlist could be the cure, with two kinds of music shown to cut motion sickness symptoms by more ...

Sunil Gupta, co-founder and CEO of Yotta Data Services, is at the forefront of India's AI infrastructure revolution. Under ...

Ferrari (RACE) stock drops after 2030 outlook signals slower growth and reduced EV goals. Learn why investors should consider ...